Global Access to Radiotherapy for Lung Cancer
Webinar | English | 1 Hr 05 Min
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
This webinar will describe the current landscape and challenges to deliver RT for lung cancer, with an emphasis on low-and middle-income countries (LMICs) and geographically underserved regions of high-income countries. 
This webinar is designed to meet the educational needs of physicians, nurses and allied health professionals, patient advocates, and researchers specializing in palliative care, medical oncology, thoracic surgery, and radiation oncology. Early career radiation oncologists and medical oncologists with a focus on global health will also benefit from this webinar.
Upon completion of this activity, the participants should be able to: 
  • Describe the current global RT capacity and identify the unique challenges for treating lung cancer with RT in LMIC.
  • Summarize the main barriers to access RT for lung Cancer, the necessary human capacity to provide RT, and challenges to train Radiation Oncologists, Therapists, and Medical Physicians in LMICs.
  • Describe research and innovation efforts aiming at addressing these disparities.
  • Corinne Faivre-Finn, FRCR, MD, PhD, Professor of Thoracic, Radiation Oncology, Consultant Clinical Oncologist, University of Manchester & The Christie NHS Foundation Trust
  • Meredith Giuliani MBBS, MEd, PhD, FRCPC, Associate Professor, Department of Radiation, Oncology, University of Toronto, Director of Education, Princess Margaret Cancer Centre, Toronto, Canada
  • Pablo MunozSchuffenegger, MD, Assistant Professor, Radiation Oncology, Pontificia Universidad Catolica de Chile, Santiago, Chile
  • Fabio Ynoe de Moraes, MD, PhD, Assistant Professor, Radiation Oncology, Queen’s University, Kingston Health Sciences Centre, Kingston, Canada

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need assistance with this activity, please email: education@iaslc.org.
Powered By